Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study
Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study
Sarah Khafaja, Kawthar Faour, Alp Dogu, Nadim Tfaily et al.
Journal
Infectious Diseases and Therapy
Topics
Travel-related health issues
article
Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study
Sarah Khafaja, Kawthar Faour, Alp Dogu, Nadim Tfaily, Sarah Merhi, Turan Buzğan, Zeinab El Zein, Stephanie Damaj, Ismail Balik, Rahmet Guner, İrem Akdemir, Mehmet Ceyhan, Ghassan S. Dbaibo, Celina F. Boutros
article en
Abstract
No abstract available for this paper.
Publication Tag
Infectious Diseases and TherapyVol. 15(3)
Institutions
Ankara University (TR), Saginaw Valley State University (US), American University of Beirut Medical Center (LB), Ankara Yıldırım Beyazıt University (TR), Jumeira University (AE), Hacettepe University (TR), American University of Beirut (LB)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study — Sarah Khafaja, Kawthar Faour, et al. · Infectious Diseases and Therapy (2026) | TGRS Research Map | TGRS